Catalyst Wire Dossier Catalyst Wire Dossier

MOVALIS

meloxicam · Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MOVALIS, covering 2009-11-18 to 2009-11-18. Get the full timeline:

Most recent: Clinical Trial Update: Assessing the Impact of MOVALIS in Osteoarthritis and Rheumatoid Arthritis Patients on Health Related Quality of Life

See pricing